CARTautoimmune Main Nav Exp Frag
What is CAR T?
What to expect
BMS CAR T studies

Bristol Myers Squibb is pioneering new medicines for autoimmune disease

Bristol Myers Squibb recognizes that people living with autoimmune diseases urgently need more treatment options. We are deeply committed to exploring the potential of CAR T cell therapy and bringing new medicines to the patients who need them

To learn more about our clinical studies in an autoimmune disease, click an icon below.

To learn more about autoimmune diseases, visit these
independent educational organizations